• 中文版
  • Home
  • About Us
    • Contract Research Organization
    • Contract Development and Manufacturing Organization
    • Accolades
    • Publications
  • Services Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
    • Pathology Core Facility
    • Immunology
    • Tumor Immunology
    • Neuroscience
    • Cell Biology
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
  • Biologics Discovery
    • Antibody Discovery
    • Protein Science
    • Biologics Analytical Services
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Call us today! +86 21 5132 0088

contact@chempartner.com
中文版
Shanghai ChemPartner Shanghai ChemPartner Shanghai ChemPartnerShanghai ChemPartner
  • Home
  • About Us
    • About ChemPartner
    • CRO
    • CDMO
    • Accolades
    • Publications
  • Services
    • Discovery Chemistry
      • Synthetic Chemistry
      • Medicinal Chemistry
      • Library Chemistry
      • Peptide Chemistry
      • Fragment Based Screening
      • Computer Aided Drug Design
      • Analytical Services
      • Protein Structure
    • Biology & Pharmacology
      • Oncology
      • Pathology Core Facility
      • Immunology
      • Tumor Immunology
      • Cell Biology
      • In Vitro Biology
      • Neuroscience
      • Metabolic & Cardiovascular Diseases
      • Epigenetics
    • DMPK / Exploratory Toxicology
      • DMPK / Exploratory Toxicology
      • Biomarkers, Preclinical & Clinical Sample Bioanalysis
      • Large molecule PK/BA services
    • Biologics Discovery
      • Antibody Discovery
      • Protein Science
      • Biologics Analytical Services
      • B Cell Cloning
    • Biologics CMC
      • Stable Cell Line Development
      • Process Development
      • Formulation Development
      • Aseptic Filling and Freeze-drying
      • Drug Developability / Manufacturability study
      • Final Container Extractables & Leachables Study
      • Analytical Development and Testing
      • GMP Production
    • Small Molecule CMC
      • Process R&D Services
      • Process Safety
      • Analytical Development
      • Pre-Formulation Development
      • Formulation Development
      • ICH Stability Studies
      • CMC CTD Support
      • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Fragment Based Screening

Home Discovery Chemistry Fragment Based Screening

Fragment Based Screening

The Fragment Based Screening Service at ChemPartner is dedicated to providing a cost-effective and high quality lead generation solutions for clients.

Our FBS team has an in depth understanding of the properties required for the discovery and development of pharmaceutical compounds and biologics. We  excel in combining effective hit generation solutions, such as fragment based screening, with Chemistry, Biology and DMPK services to drive drug discovery projects forward efficiently.

Our FBS capabilities include:

Screening of fragment libraries

  • Ligand Observe NMR methods
  • Saturation Transfer Difference (STD)
  • WaterLOGSY (wLOGSY)
  • Carr-Purcell-Meiboom-Gill (CPMG)

Library preparation of client or custom libraries

  • Identity, solubility, and purity determination
  • Automated smart pooling
  • Positive control at regular intervals
  • Diversity analysis

Follow-up analysis of hits

  • Validation (follow-up of singletons)
  • Rank-order; clustering of hits

Target Protein Generation

  • Protein synthesis and purification

Target Preparation

  • Screen design
  • Sample optimization
  • Experimental optimization

Complimentary Capabilities

  • Orthogonal screening methods e.g. MST, DSF, HCS, SPR, TSA
  • X-Ray Crystallography
  • Computational Chemistry
  • SAR design and synthesis to support hit optimization
  • Biological Assays design and support

Fragment Library

The ChemPartner Fragment library has been specifically designed by computational and medicinal chemists to investigate as much chemical space as possible, within a specific range of molecular and physicochemical properties, making any hits discovered the ideal starting point for a drug discovery project.

Compounds in the ChemPartner library are selected on chemical diversity, good solubility in aqueous media and adhere to the ‘rule of three’ criteria:

  • Molecular weight < 300
  • clogP ≤ 3
  • Number of hydrogen bond donors ≤ 3
  • Number of hydrogen bond acceptors ≤ 3

Our unique fragment library of >2000 compounds is a combination of specifically selected fragments from:

  • Commercial fragments
  • Internal small molecule collections
  • Fragments based upon FDA approved drugs
  • 19F- containing fragments
  • Covalent fragments

Screening external libraries

In addition to the ChemPartner fragment library, we are also able to use our FBS platform to screen:

  • Client-provided fragment libraries
  • Client-selected commercial libraries
  • Custom commercial libraries

 

Additional capabilities

In addition to our FBS platform, ChemPartner is able to provide:

  • NMR-based compound quality check
    • Identity
    • Purity
    • Solubility
  • Fragment pooling
    • Randomized pooling
    • Smart pooling

Versatile NMR Screening Methods

Our primary recommendation would be to conduct an initial fragment screen of a1000 member fragment library using NMR as the primary technique with confirmation of hits by orthogonal methods.

The first stage would be to screen the library using an NMR STD protocol, followed by further investigation of the hits identified using NMR wLOGSY or CPMG.

ChemPartner has access to a number of high field NMR instruments (600MHz or 700MHz) with cryoprobe technology.

Fragment hits using three NMR techniques

CPMG                                                          STD                                                          wLOGSY

Hits generated using the NMR platform could then be profiled further using orthogonal biophysical techniques such as MST, DSF, and SPR to determine Kd and kinetics.

      

SPR Equipment                                                      MST Trace

Hit Elaboration

ChemPartner is confident that our FBS platform will provide you with high quality hit compounds.

Our crystallography team can obtain high-resolution structures to guide the subsequent fragment elaboration.

In addition our skilled and experienced synthetic, medicinal and computational chemists can support the development of your hit molecules into clinical candidates.

  • Service Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
      • OncoCP Database
    • Pathology Core Facility
      • Histopathology
      • Molecular Pathology
    • Immunology
      • Primary immune cell assays
      • Immune cell line assays
      • Autoimmune disease models
      • In vivo PD models
      • Immune profiling for MOA
    • Tumor Immunology
    • Neuroscience
      • Volume Discount Fast services for Neuroscience
      • Behavioral Pharmacology
      • In vivo Pain Models
      • Non-Human Primate Cognition
      • In Vitro Electrophysiology
    • Cell Biology
      • Target Validation
      • Cell-based Assays
      • Cancer Cell Line Panel Screen
      • Biomarker Analysis
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
      • In vitro ADME
      • Pharmacokinetics
      • Exploratory Toxicology
      • Bioanalysis
      • Regulatory filing
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
      • Monoclonal Antibodies
      • Antibody Drug Conjugates
      • Bispecific Antibodies
      • Proteins & Peptides
      • Immunogenicity
  • Biologics Discovery
    • Antibody Discovery
      • Hybridoma
      • Antibody Engineering
      • Phage Display
      • Antibody-Drug Conjugate
    • Protein Science
    • Biologics Analytical Services
      • mAb Release Tests and Extended Characterization
      • Antibody-Drug Conjugate(ADC) Analysis
      • Therapeutic Protein Characterization
      • Biomolecular Interaction Analysis
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing

Give us a Message

You can leave us a message by quick contact box and we'll get back to you, asap. Thanks!

Send Message

Logo

ChemPartner is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry.

Get started today.

Contact Us
  • Shanghai ChemPartner Co., Ltd.
  • 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai China, 201203
  • +86 21 5132 0088
  • contact@chempartner.com

© 2021 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  About Us  Careers  Contact Us  Privacy Policy  Sitemap

  • Home
  • Contact
  • Buy Highend